Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02775318Phase 1Completed
Phase 1, single-blind, single-arm trial of bupivacaine in cerebral vasospasm, sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoints: Glasgow Coma Scale at 48 hours, Motor Power on Motor System Examination at 48 hours and 1 more. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02775318.